Nebraska Cancer Specialists — Grand Island, Nebraska

Nebraska Cancer Specialists is a clinical research site located in Grand Island, Nebraska, United States 68803.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Nebraska Cancer Specialists has participated in 6 clinical trials with 6 currently active.

Therapeutic areas: Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Neoplasms, Prostate Cancer Recurrent.

Sponsors: MacroGenics, BeiGene, Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Cancer Specialists?

Nebraska Cancer Specialists has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Cancer Specialists conducted?

Nebraska Cancer Specialists has 6 clinical trials on record, with 6 currently active. Their work covers Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Neoplasms, Prostate Cancer Recurrent.

Is Nebraska Cancer Specialists accredited by Crixeo Health?

Yes — Nebraska Cancer Specialists holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Nebraska Cancer Specialists?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.